US Congress to act now on drug safety legislation

Drug Safety :: US Congress to act now on drug safety legislation

Today's news that the Food and Drug Administration (FDA) is examining whether the maker of Zyprexa failed to submit clinical trial data about the harmful side effects of the antipsychotic drug underscores the urgent need for Congress to pass drug-safety legislation.

The Senate is slated next week to vote on a package of reforms.

"We've seen too many cases where drug companies downplayed, hid or 'forgot' their clinical trial data that showed harmful side effects, and patients ultimately suffered," said Bill Vaughan, senior policy analyst for Consumers Union, publisher of Consumer Reports. "Congress has got to put a stop to this gaming of the safety system by the drug companies, and pass real reforms now that make drug-risk information public."

The New York Times reported today that the FDA has questions about an Eli Lilly & Co. document from February 2000 that found patients taking Zyprexa in a clinical trial were three and a half times as likely to develop high blood sugar as a placebo. The document was not submitted to the FDA, and a few months later Lilly provided data to the agency that showed almost no difference in blood sugar between patients who took Zyprexa and those who did not. Untreated high blood sugar can eventually lead to diabetes.

In explaining the discrepancy, Eli Lilly told the Times the document was a preliminary analysis, and a final quality check of the data found that the analysis was incorrect.

The Senate is tentatively slated to vote next week on a major prescription drug bill that includes numerous safety reforms. The legislation includes requiring drug companies to register and make public most clinical trial results, as well as giving the FDA the authority to require label changes, post-market safety studies and other tools to monitor drugs for safety issues once they are on the market.

"The Senate has an opportunity to pass a common-sense bill that will better protect patients from drug risks, while still ensuring life-saving medicines get quickly to market," Vaughan said. "Patients and their doctors need to know the risks of a drug, and Congress has the power to stand up to the drug companies and make that happen."




(Drug Safety :: US Congress to act now on drug safety legislation published at SpiritIndia on Thursday, April 26, 2007)

Drug Safety

Search more information on Drug Safety, Drug Safety books

Recently posted related articles on Drug Safety :

1. Drug Safety :: Lilly's CEO Calls for Reform of Nation's Drug Safety System
2. Drug Safety :: AARP praises drug safety, generic drug market access provisions of FDA Bill
3. Drug Safety :: Importation Scheme Undermines Intent of Drug Safety Bill
4. Drug Safety :: US Senate gives FDA more power to deal with unsafe medicines
5. Drug Safety :: Changing the Management of Drug Safety and Pharmacovigilance
6. Drug Safety :: US Congress to act now on drug safety legislation
7. Drug Safety :: FDA causes unnecessary scare about common painkillers
8. Drug Safety :: Overwhelming scientific evidence confirms aspartame safety
9. Drug Safety :: FDA announces audio broadcasts on emerging drug safety information
10. Drug Safety :: Direct to Consumer Advertising of Prescription Drugs Influences Behavior, Attitudes and Knowledge

Most related articles:

- Drug Safety :: US Congress to act now on drug safety legislation
- Drug Safety :: US Government failed to protect Americans from dangerous prescription drugs - 13.5
- Drug Safety :: FDA proposes new measures to strengthen drug safety - 11.5
- Drug & pharmaceutical industry defensive for medicare bill - US - 9.9
- Drug Safety :: FDA reinforces commitment to drug safety - 9.9
- Drug Safety :: Importation Scheme Undermines Intent of Drug Safety Bill - 9.2
- Drug :: Mike Leavitt regarding Senate Vote on Dorgan Importation Amendment - 9.1
- Drug Safety :: National experts and nonprofit organizations call to end FDA user fees and to improve drug safety - 8.4
- Stent :: FDA probes safety of popular heart stent - 8.3
- Drug Safety :: US Senate gives FDA more power to deal with unsafe medicines - 8


»»   Influenza :: Roche update on Tamiflu for pandemic influenza preparedness
««   Parkinson's Disease :: Blood test can diagnose and monitor treatment of Parkinson's disease

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com